Is BioNxt Solutions Inc. (BNXT.CN) a Buy, Sell, or Hold?
CNQ : BNXT.CN
BioNxt Solutions Inc.
$0.31 CAD
$0.01 (3.33%)
- Volume
- 17.35K
- Average Volume
- 19.53K
- Market Capitalization
- $40.3M
- P/E Ratio
- -4.06
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $1.10
- Year Low
- $0.28
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.01
Company Overview
CNQ
Hugh A. D. Rogers
Drug Manufacturers - Specialty & Generic
Healthcare
BNXT.CN
25
CA
CAD
Liquidity Metrics
-0.86
0.01
0.01
0.00
0.00
Sales & Valuation
-$
0.00
-5.31
-9.02
-0.04
Profitability
-$0.0595
-$7.03M
0.00%
0.00%
111.33%
-2785.45%
P/E Metrics
-4.06
0.10
0.10
Analyst Price Target & Rating
2/5
0 Analysts
%
Financial Health Scores
-418.63
2/9
-$6.51M
$333.76K
$7.65M
-$8.21M
Key Metrics (TTM)
No key metrics data available.
Company Executives
| Name | Title |
|---|---|
| Hugh A. D. Rogers | Co-Founder, Chief Executive Officer & Director |
| Wolfgang Probst | Co-Founder, Chief Financial Officer & Corporate Secretary |
| Wolfgang Wagner | Head of Research & Development |
| Florian A. Sahr | Head of Project Management |
| Raimar Lobenberg | Co-Founder & Director |
Poll Results
No votes yet today — be the first to share your view!
About BioNxt Solutions Inc. (CNQ:BNXT.CN) Stock
Headquartered in Vancouver, Canada, BioNxt Solutions Inc., established in 2017, operates as a bioscience company across Germany, Switzerland, Austria, Israel, and its home country. The firm focuses on developing innovative drug delivery systems, including transdermal patches and oral dissolvable films, specifically for neurological medications. It also advances psychedelic medicine applications to treat various mental health conditions such as depression, anxiety, addiction, and trauma-related stress disorder. Furthermore, BioNxt is engaged in creating point-of-care diagnostics, comprising rapid tests and biosensor screening tools, aimed at early disease detection, improved treatment efficacy, and enhanced disease management. This diagnostic portfolio features a COVID-19 PCR kit, alongside ... oral biosensors for peri-implantitis, H1N1 (swine flu), and H5N1 (avian flu). Complementing its development efforts, the company provides analytical testing and consulting services, and is involved in pathogen and oral health diagnostics, thin film drug formulation, and the production and formulation of psychedelic pharmaceuticals. The company adopted its current name in November 2022, having previously been known as XPhyto Therapeutics Corp.
Frequently Asked Questions
-
What is the current BioNxt Solutions Inc. (BNXT.CN) stock price?
-
BioNxt Solutions Inc.(CNQ:BNXT.CN) stock price is $0.31 in the last trading session. During the trading session, BNXT.CN stock reached the peak price of $1.1 while $0.28 was the lowest point it dropped to. The percentage change in BNXT.CN stock occurred in the recent session was 3.33% while the dollar amount for the price change in BNXT.CN stock was $0.01.
-
BNXT.CN's industry and sector of operation?
-
The CNQ listed BNXT.CN is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of BNXT.CN?
-
Hugh A. D. Rogers | Co-Founder, Chief Executive Officer & Director
Wolfgang Probst | Co-Founder, Chief Financial Officer & Corporate Secretary
Wolfgang Wagner | Head of Research & Development
Florian A. Sahr | Head of Project Management
Raimar Lobenberg | Co-Founder & Director -
How many employees does BNXT.CN have?
-
Number of BNXT.CN employees currently stands at 25. BNXT.CN operates from 1928 Linden Road, Vancouver, BC V6J 3B1, CA.
-
Link for BNXT.CN official website?
-
Official Website of BNXT.CN is: http://www.bionxt.com
-
How do I contact BNXT.CN?
-
BNXT.CN could be contacted at phone #780 818 6422 and can also be accessed through its website. BNXT.CN operates from 1928 Linden Road, Vancouver, BC V6J 3B1, CA.
-
How many shares of BNXT.CN are traded daily?
-
The average number of BNXT.CN shares traded daily for last 3 months was 19.53K.
-
What is the market cap of BNXT.CN currently?
-
The market value of BNXT.CN currently stands at $40.3M with its latest stock price at $0.31